Your browser doesn't support javascript.
loading
Risks and benefits of low-dosage cyclosporin in rheumatoid arthritis.
Pasero, G; Ferraccioli, G F; Portioli, I.
Affiliation
  • Pasero G; Chair of Rheumatology, Department of Internal Medicine, University of Pisa, Pisa, Italy.
BioDrugs ; 7(5): 376-85, 1997 May.
Article in En | MEDLINE | ID: mdl-18031101
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: BioDrugs Journal subject: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Year: 1997 Type: Article Affiliation country: Italy
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: BioDrugs Journal subject: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Year: 1997 Type: Article Affiliation country: Italy